Besides the new cases, 15,858 recoveries were reported in the country in the same period, the Ministry said.

The total count includes 1,35,926 active cases and 1,05,89,230 recoveries.

The COVID-19 death toll has reached 1,55,447 with 87 people succumbed to the virus in the last 24 hours.

As many as 75,05,010 COVID-19 vaccines have been administered in the country so far.

A total of 20,40,23,840 samples have been tested for the coronavirus as of February 10. Of these, 6,99,185 samples were tested on Wednesday, the Indian Council of Medical Research (ICMR) informed.

The post India registers 9,309 new COVID-19 cases, 87 deaths appeared first on The Gulf Indians.

Moreover, with 117 deaths related to the novel coronavirus infection, total fatality in the country has surged to 1,53,587.

India currently has 1,77,266 active cases and 1,03,45,985 people have been recovered and discharged so far.

According to the Indian Council of Medical Research (ICMR), 19,30,62,694 samples have been tested for Covid-19 detection up to January 25 with 7,25,577 of them being tested on Monday.

The post India reports lowest daily spike in eight months appeared first on The Gulf Indians.

Out of the total cases, active cases further dropped to 2.08 lakh while recoveries went up to 1,02 crore. With 145 deaths reported on January 17, the toll stands at over 1.52 lakh. Kerala recorded 5,005 new cases, more than 36 percent of all. Maharashtra reported 3,081 cases.

Now the total caseload in the country has mounted to 1,05,71,773. The active cases tally in India stands at 2,08,012 and total recovered/discharged cases at 1,02,11,342.

On January 17, active cases declined below 2 percent of the total cases reported in the country for the first time. Daily new COVID-19 cases have stayed below the 20,000 mark from the last 10 days.

Over 2.24 lakh priority group individuals have been vaccinated at the end of two days of India’s mega inoculation drive. Out of the beneficiaries, only 447 adverse events cases have been reported, 3 of them required hospitalization, with 2 being discharged already, the Union Ministry said.

The post India records lowest spike in COVID-19 cases since mid-June appeared first on The Gulf Indians.

With 214 fresh deaths, India’s coronavirus death toll now stands at 1,49,649.

Among 1.03 crore total cases, there are 2,43,953 active cases while 99,46,867 have recovered. In the past 24 hours, India saw 19,557 recoveries, as per the Union Health Ministry.

Maharashtra reported 3,282 new cases and 35 deaths in the last 24 hours. There are now 53,137 active cases in the state, the health department informed. So far, 18,36,999 people have recovered, while the death toll stands at 49,666.

Kerala reported 4,600 new cases and 4,668 recoveries on Sunday. With this, the total number of active cases in the state now stands at 65,278.

As many as 424 new coronavirus cases and 708 recoveries were reported in the national capital on Sunday, as per the Delhi Health Department. The total number of positive cases now stands at 6,26,872, while the death toll stands at 10,585, including 14 on Sunday. There are currently 5,044 active cases in the national capital.

With 7,35,978 samples tested for the coronavirus on Sunday, the total number of samples tested so far stands at 17,56,35,761, the Indian Council of Medical Research (ICMR) informed.

On January 3, the Drugs Controller General of India (DCGI) granted permission for restricted use in an emergency situation to vaccines of Serum Institute of India and Bharat Biotech. All India Institute of Medical Sciences (AIIMS) director Dr Randeep Guleria clarified that approval of COVAXIN, Bharat Biotech’s COVID-19 vaccine is for an emergency situation and not emergency use authorisation which is given to Serum Institute of India’s COVISHIELD.

The post With 16,504 new COVID-19 cases, India’s total reaches 1,03,40,470 appeared first on The Gulf Indians.

The total number of Covid-19 positive cases in India now stands at 1,00,75,116, while active cases tally is at 2,92,518.

With 301 more deaths, the Covid-19 toll in the country rose to 1,46,111.

The country also reported 30,376 recoveries in the last 24 hours, taking the total recovered cases to 96,36,487.

According to Indian Council of Medical Research, a total of 16,31,70,557 samples tested for COVID-19 up to December 21. Of these, 10,72,228 samples were tested on December 22.

Meanwhile, the new strain of coronavirus in the United Kingdom has triggered panic across the world. In a bid to block the new mutant of the coronavirus from spreading, the Indian government has announced that all the flights from the UK will be suspended from Tuesday till December 31.

All the passengers arriving in India till Tuesday (December 22) will have to get themselves tested.

Meanwhile, countries across the globe shut their borders to Britain on December 21 due to fears about a highly infectious new coronavirus strain, causing travel chaos and raising the prospect of food shortages days before Britain is set to leave the European Union.

India, Pakistan, Poland, Spain, Switzerland, Sweden, Russia, Jordan, France, Hong Kong and other countries suspended travel for Britons after Prime Minister Boris Johnson said a mutated variant of the virus had been identified in the country.

The post India records 19,556 new COVID-19 cases, lowest in six months appeared first on The Gulf Indians.

Among the 99.3 lakh coronavirus cases, India now has a total of 3,32,002 active Covid-19 cases while 94,56,449 have been discharged so far. In the past 24 hours, the country also recorded 33,813 new discharges.

With 387 new Covid-19 deaths in 24 hours, India’s death toll has gone up to 1,44,096.

The national recovery rate is at 95.21 percent while the COVID-19 case fatality rate stands at 2.46 percent. The COVID-19 active caseload remained below 4 lakh for the 10th consecutive day.

In India’s worst hit state, Maharashtra, the seven day average of daily cases has dropped nearly 82 percent from the peak of 22,149 seen on September 17.

According to the Indian Council of Medical Research (ICMR), a total of 15,66,46,280 samples have been tested for COVID-19 upto December 15 with 10,85,625 samples being tested on December 15.

Union Health Secretary Rajesh Bhushan said preparations are underway to prepare local officials to receive and administer vaccines, a process that is likely to cover close to 300 million people by the middle of next year.

He also said that India is showing a sustained improvement in containing the Covid-19 outbreak. But at the same time , they warned that trends in other countries are also a strong reminder of how the situation can quickly go out of control even if one peak is contained.

The post India sees 26,382 new COVID-19 cases, 387 new deaths appeared first on The Gulf Indians.

With 336 new deaths, the toll mounted to 1,43,355 as of Monday, with total active cases at 3,52,586.

The health ministry said that more than 70 percent of the deaths occurred due to comorbodities.

The total discharged cases are at 93,88,159 with 30,695 new discharges in the last 24 hours.

The COVID-19 caseload of the country remained below 4 lakh for the eighth consecutive day on Monday. The national recovery rate is at 94.98 percent, while the case fatality rate stands at 1.45 percent.

India’s Covid-19 tally had crossed the 20-lakh mark on August 7, 30 lakh on August 23 and 40 lakh on September 5.
It went past 50 lakh on September 16, 60 lakh on September 28,
70 lakh on October 11, crossed 80 lakh on October 29 and surpassed 90 lakh on November 2.

A total of 15,45,66,990 samples tested for COVID-19 up to December 13. Of these, 8,55,157 samples were tested yesterday said Indian Council of Medical Research.

On December 13, Delhi recorded 1,984 fresh Covid-19 cases which pushed the infection tally to 6.07 lakh, while the death toll crossed the 10,000 mark with 33 new fatalities.

These fresh cases came after conducting 72,335 tests including 35,611 RT-PCR tests, according to the latest bulletin issued by the Delhi health department.

With over 98.57 lakh total coronavirus cases, India’s active caseload continues to decline and is currently below 3.6 lakh, the union ministry of health said.

The post Daily COVID-19 cases in India dip below 30,000 for third time in Dec appeared first on The Gulf Indians.

The total coronavirus cases climbed to 96,77,203 with 32,109 new infections being reported in a day, while the death toll crossed to 1.4 lakh with 391 new fatalities.

At 3,96,729, the Covid-19 active caseload in India is now below the 4-lakh mark.

As per Union Health Ministry data on Monday, total discharged cases in India stands at 91,39,901 with 39,109 new discharges in the last 24 hours.

India’s Covid-19 tally had crossed the 20-lakh mark on August 7, 30 lakh on August 23 and 40 lakh on September 5.

It went past 50 lakh on September 16, 60 lakh on September 28, 70 lakh on October 11, crossed 80 lakh on October 29, and surpassed 90 lakh on November 20.

According to the Indian Council of Medical Research (ICMR), a cumulative total of 14,77,87,656 samples have been tested for COVID-19 up to December 6 with 8,01,081 samples being tested on Sunday.

The Union health ministry had said earlier that the country does not need to vaccinate all of its 1.3 billion people if it manages to break the transmission of coronavirus disease.

Meanwhile, the Serum Institute of India have become the first indigenous company to apply to the Drugs Controller General of India (DCGI) seeking emergency use authorisation for the Oxford Covid-19 vaccine in the country citing unmet medical needs due to the pandemic and in the interest of the public at large.

The post India’s active coronavirus cases fall below 4 lakh appeared first on The Gulf Indians.

The total coronavirus cases mounted to 91,39,865 while the death toll climbed to 1,33,738 with 511 new fatalities, the data updated at 8 am showed.

The number of active cases remained below 5 lakh for the thirteenth consecutive day. There are 4,43,486 active cases of coronavirus infection in the country as on date which comprises 4.85 per cent of the total caseload, the data stated.

The national recovery rate was recorded 93.68 per cent, while the COVID-19 case fatality rate stands at 1.46 per cent.

India’s COVID-19 tally had crossed the 20-lakh mark on August 7, 30 lakh on August 23 and 40 lakh on September 5. It went past 50 lakh on September 16, 60 lakh on September 28, 70 lakh on October 11, crossed 80 lakh on October 29, and surpassed 90 lakh on November 20.

According to the ICMR, over 13.25 crore samples have been tested up to November 22 with 8,49,596 samples being tested on the day.

The post India’s COVID-19 caseload breaches 91-lakh mark appeared first on The Gulf Indians.

A total of 585 people succumbed to the deadly virus, taking the overall fatalities to 1,31,578. However the country’s new deaths per million due to coronavirus disease in the past seven days has continued to remain the lowest in the world.

The total active cases stand at 4,43,303 after a decrease of 3,502 in the last 24 hours.
The total discharged cases are at 83,83,603 with 48,493 new recoveries in the last 24 hours.

For the 12th day today, India has reported less than 50,000 daily coronavirus cases. According to Health ministry, the recovery rate now stands at 93.58%.

The Indian Council of Medical Research said that a total of 12,85,08,389 samples have been tested for Covid-19 up to 18 November. Of these, 10,28,203 samples were tested yesterday, the ICMR added.

As covid-19 cases and death continues to rise in Delhi , Tata group in collaboration with Apollo group of hospitals launched an indigenous testing kit based on the gene-editing technology CRISPR called Feluda.

The test is likely to be cheaper than the current gold standard RT-PCR and equally accurate, helping in scaling up Covid-19 testing as it would need a machine that is widely available with laboratories and science institutions.

The global infection tally has gone up to 56,187,563 with the United States continuing to report the maximum number of Covid-19 cases at 11,525,540. The virus has claimed 1,348,600 lives across the globe, according to Johns Hopkins University’s tracker.

The post India’s COVID-19 cases jump to 45,576, Feluda testing kit launched in Delhi appeared first on The Gulf Indians.

For eleventh day, India has reported less than 50,000 daily coronavirus cases. The last time daily new cases crossed the 50,000 threshold was on November 7.

Delhi reported the most ( 6,396) new cases in the last 24 hours, followed by Kerala (5,792) , West Bengal (3,654) , Maharashtra (2,732) and Haryana (2,450) . These top five states account for nearly half (54 percent) of all the new cases in India.

Maharashtra has 82,904 active coronavirus cases, the highest in the country, followed by Kerala with 70,191 and Delhi with 42,004.

Considering the spike in COVID-19 cases in Delhi, Noida administration deployed COVID-19 testing team to conduct random tests of commuters at Delhi-Noida Border.

According to the Indian Council of Medical Research (ICMR), 9,37,279 samples for COVID-19 were tested on November 17 while a total of 12,74,80,186 samples tested so far.

On November 17, the Union Health Ministry saidthat the cumulative positivity is at 7.01 per cent while the Recovery Rate has improved to 93.42 per cent.

Maharashtra, Kerala, Delhi, West Bengal, Karnataka, Uttar Pradesh, Haryana, Rajasthan, Chhattisgarh and Andhra Pradesh account for 76.7 per cent of total active COVID-19 cases in the country, it said.

Rajesh Bhushan, Secretary, Ministry of Health and Family Welfare, has said that India continues to be among the countries with lowest cases per million population in the world, the country’s figure is as low as 6,430 while there are countries having more than 20,000 cases per million population

The post India’s COVID-19 tally crosses 89-lakh mark appeared first on The Gulf Indians.

With 520 new deaths reported in the last 24 hours, the toll mounts to 1,29,188.

The total number of active cases stand at 4,80,719 after a decrease of 3,828 in the last 24 hours.

Total discharged cases stand at 81,63,572 with 47,992 new discharges in the last 24 hours.

#CoronaVirusUpdates:

📍Total #COVID19 Cases in India (as on November 14, 2020)

➡️93.05% Cured/Discharged/Migrated (8,16,35,72)
➡️5.48% Active cases (4,80,719)
➡️1.47% Deaths (1,29,188)

Total COVID-19 confirmed cases = Cured/Discharged/Migrated+Active cases+Deaths pic.twitter.com/KXjPLi1Tmd

— #IndiaFightsCorona (@COVIDNewsByMIB) November 14, 2020

The Ministry of Health revealed that, the recovery rate in India is at 93.05 percent while the fatality rate is at 1.47 percent. The active cases comprise of 5.48 percent of the total cases as of Saturday.

Maharashtra has reported 85,583 active cases, 16,05,064 recoveries and 45,682 deaths due to the disease so far while Karnataka recorded 29,489 active cases, 8,14,949 recoveries and 11,474 deaths so far.

The national capital reported 43,116 active cases and 7,332 deaths while 4,16,580 people recovered from the infection till now.

According to the Indian Council of Medical Research (ICMR), a total of 12,40,31,230 samples have been tested for COVID-19.

COVID-19 Testing Update. For more details visit: https://t.co/dI1pqvXAsZ @MoHFW_INDIA @DeptHealthRes #ICMRFIGHTSCOVID19 #IndiaFightsCOVID19 #CoronaUpdatesInIndia #COVID19 pic.twitter.com/hrWG5TkchP

— ICMR (@ICMRDELHI) November 14, 2020

The post India reports 44,684 new coronavirus cases appeared first on The Gulf Indians.

Earlier ICMR and SII have further collaborated for the clinical development of development of COVOVAX, developed by American company Novavax and upscaled by SII.

SII said it has enrolled 1,600 participants in India for late-stage trials of AstraZeneca’s candidate, and also plans to seek regulatory approval to run late-stage trials for Novavax vaccine.

Covishield is the AstraZeneca-Oxford University COVID-19 vaccine candidate and is the most advanced in human testing in India. SII and ICMR is planning to pursue early availability of the shot in India.

The ICMR had funded the clinical trial site fees for Covishield. SII and ICMR are currently conducting mid-stage clinical trials of the shot at 15 centres across India.

The two frontrunner coronavirus vaccines developed by Pfizer Inc and Russia have shown positive results and are said to be effective by over 90% against COVID-19. Now Moderna is also getting closer to releasing the data on its late-stage trials of the corona vaccine candidate.

Meanwhile, in India, experts have said that Pfizer news may not be of much use in India as the Pfizer coronavirus vaccine needs storage at extreme cold temperature (-70 degree Celsius) and arranging such cold chains would be a huge logistical issue.

The post Forty million doses of COVID-19 vaccine produced, SII appeared first on The Gulf Indians.

The total number of active cases now stands at 5,05,265 after a decrease of 4,408 in the last 24 hours.

Total recovered cases are at 79,59,406 with 42,033 new discharges in the last 24 hours.

India’s COVID-19 active cases have fallen below six percent of the total cases.

In a tweet, the Health Ministry said, “ Demonstrating a landmark achievement, India’s active cases have fallen below 6% of the total cases. The recovered cases have leaped past 92% of the cumulative cases.”

In another tweet, it said, “Caliberated and effective strategy of the Center focused on high levels of testing for early identification combined with timely tracing, isolation and hospitalisation of the severe cases have resulted in a manageable number of active cases and continuously rising number of recoveries.”

Delhi has overtaken Maharashtra and Kerala by reporting 7,745 infections in a span of 24 hours to become the largest contributor to the single-day infections.

According to the Indian Council of Medical Research (ICMR), a total of 11,96,15,857 samples have been tested for coronavirus till November 9. Of these 10,43,665 samples were tested on November 9.

The post India’s COVID-19 active cases falls below six percent of the total cases appeared first on The Gulf Indians.

According to the updated health ministry data, 557 coronavirus patients succumbed to the coronavirus in the past 24 hours, taking the death toll in the country due to the infection to over 1.25 lakh.

India currently has 5,16,632 active coronavirus cases after a decrease of 4,141 in the last 24 hours. So far, 78,19,887 people have been discharged. On Friday, 53,920 coronavirus patients were discharged.

According to the Indian Council of Medical Research (ICMR), India has so far tested 11,65,42,304 samples to detect coronavirus. Of these, 11,13,209 samples were tested on November 6.

India’s single-day coronavirus recoveries exceeded daily new infections successively for the past five weeks, while active cases are on a sustained decline.

There is a continuous decline in average daily new cases for the last five weeks. The ministry had said on Friday that 80 per cent of the new recovered cases are observed to be concentrated in 10 states and union territories.

The post India registers 50,357 new coronavirus cases appeared first on The Gulf Indians.

The total coronavirus cases mounted to 83,64,086 and the deaths have climbed to 1,24,315 with the virus claiming 704 lives in the last 24 hours in the country.

The COVID-19 case fatality rate was recorded at 1.49 percent. So far, there are 5,27,962 active cases of COVID-19 which comprises 6.31 percent of the total caseload.

According to the ICMR, a cumulative total of 11,42,08,384 samples have been tested up to November 4, with 12,09,425 samples being tested on November 5.

Adar Poonawalla, chief executive officer (CEO) of Pune-based pharmaceutical company Serum Institute of India (SII) said that the covid vaccine is likely to be available in the country by January 2021 provided approvals from regulatory bodies are in place and only if its proven immunogenic and efficacious.

The SII is working in collaboration with British- Sweden pharma major AstraZeneca to produce the potential covid-19 vaccine Covishield.

The CEO of the world’s largest drug manufacturing firm also said that the firm is in talks with the government over the pricing of the vaccine and assured that it will be available at a reasonable price.

The post COVID-19: India reports 50,210 new cases appeared first on The Gulf Indians.

The pharma company’s immediate focus is to conduct the Phase 3 trials successfully across sites in the country.

The company’s vaccine candidate, Covaxin, has been developed in collaboration with the Indian Council of Medical Research-National Institute of Virology using inactivated Sars-Cov-2. The virus was isolated in an ICMR lab.

The price of the vaccine is yet to be determined, as the company is still looking at the cost of product development.

Bharat Biotech received approval from the Drugs Controller General of India to conduct Phase 3 clinical trial to establish the efficacy of the vaccine candidate. The company has begun site preparatory exercises for Phase 3, recruitment and dosage will begin in November.

The trial is conducted in nealy 30 sites around 14 states. About 2,000 subjects are enrolled per hospital and will provide tow doses each of the vaccine and placebo recipients.

The pharma company is looking to supply for both government and private markets. It is also in its preliminary discussions with other countries for probable supply.

Nearly Rs 350-400 crore is invested for the development of vaccines and the new manufacturing facilities, which include investments for conducting the Phase 3 clinical trials, in the next three months.

The post Bharat Biotech to launch Covaxin in mid-2021 appeared first on The Gulf Indians.

India also witnessed a dip of 8448 in its active cases in the last 24 hours. As of Wednesday morning, there are 7,40,090 active cases of coronavirus in India.

For the fifth consecutive day, the active cases of coronavirus remained below 8 lakh in India.

India has a recovery rate of 88.8 percent. Six states – Maharashtra, Karnataka, Kerala, Tamil Nadu, Andhra Pradesh and West Bengal- account for 64 percent of the country’s total active cases.

According to the ICMR, a cumulative total of 9,72,00,379 samples have been tested up to October 20 with 10,83,608 samples being tested on Tuesday (October 20).

However, a top ICMR official warned that a person may get reinfected with Covid-19 if the antibodies against the infection diminish in the body in five months’ time after recovery.

Officials at the World Health Organisation reiterated the importance of adhering to quarantine rules for those who test positive and those who have come in contact with a positive case, as Europe faces a surge in numbers.

Globally, the infections have topped 40.2 million, with over 1.1 million deaths. Soaring cases in US battleground states pose a challenge for President Donald Trump two weeks before the election.

The post India reports 54,044 fresh coronavirus cases appeared first on The Gulf Indians.

In a single day, 579 coronavirus positive patients succumbed to the Covid-19 infection, according to the Health Ministry data.

India stood second behind the United States in terms of total cases of coronavirus. The country tops in terms of the number of recovered cases and third in terms of fatalities globally behind the US and Brazil.

India’s total Covid-19 tally has climbed to 75,50,273. India has also seen a dip of 11,256 in its active cases since Sunday. As of Monday morning, there are 7,72,055 active cases of coronavirus in India. So far, 66,63,608 have recovered from the infection and 1,14,610 people have died from the coronavirus.

Maharashtra, Andhra Pradesh and Karnataka have reported the highest number of cases. However, infections are rising rapidly in states like Tamil Nadu, Uttar Pradesh and West Bengal. Yet, India’s recovery rate continues to rise and now stands at 88 percent.

The Indian Council of Medical Research (ICMR) has said that 9,50,83,976 samples were tested for COVID-19 in the country till yesterday (October 18). Of these, 8,59,786 were tested on Sunday (October 18).

The post Coroanvirus caseload over 75lakh in India appeared first on The Gulf Indians.

Meanwhile , 55,300 new cases of COVID-19 cases and 706 deaths in 24 hours takes india’s overall tally to 71,75,881 including 8,38,729 active cases, 62,27,296 cured and 1,09,856 deaths, said the Union Health Ministry.

#IndiaFightsCorona

India is showing a trend of declining average daily cases over the past 5 weeks.

After a month, on 9th Oct, active cases fell below the 9L mark and have steadily followed a downward slope since. pic.twitter.com/sV8ojVR4ne

— Ministry of Health (@MoHFW_INDIA) October 13, 2020

With 77,760 new recoveries, India’s recovery rate has gone up to 86.8 percent. The Covid death rate in India, which has been reporting between 800 and 900 deaths a day since early August, is 1.5 per cent.

This is the first time in two months that India has reported around 55,000 coronavirus cases in a day and second consecutive day when the total new infections were under 70,000 since the September surge.

The country’s 24-hour COVID-19 cases have come down to an average of 72,000 to 74,000 from the earlier 90,000-plus figure.

The total number of samples tested up to October 12 is 8,89,45,107 including 10,73,014 samples tested on Monday, according to Indian Council of Medical Research. Now the daily positivity rate in India stands at 5.2 percent

The post COVID-19: India shows a trend of declining average daily cases appeared first on The Gulf Indians.

The number of new fatalities also saw a drop for the ninth consecutive day. India recorded 816 deaths due to the infection in the last 24 hours.

Nearly 84 per cent of these fatlities are reported from 10 states, with Maharashtra having reported maximum number (308) of these deaths. The fatality count now stands at 1,09,150.
The number of active cases fell further to 8,61,853, while 61,49,535 patients have cured of the disease, according to health ministry.

It took 110 days for the Covid-19 cases in the country to reach one lakh while it had taken 59 days more to go past the 10-lakh mark.

The Covid-19 case fatality rate (CFR) stands at 1.54 per cent, the health ministry had said on October 11.

According to Indian Council of Medical Research (ICMR), a cumulative total of 8,68,77,242 samples have been tested till October 10 with 10,78,544 samples being tested on October 10.

The post COVID-19: India’s daily count falls, total tally crosses 71 lakh. appeared first on The Gulf Indians.